Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of ANAkinra During Adult " COVID-19 " With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial

NCT04364009 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT04364009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04364009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of ANAkinra During Adult " COVID-19 " With Aggravating Respiratory Symptoms: a Multicenter Open-label Controlled Randomized Trial
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Terminated
Start date
April 27, 2020
Completion date
November 3, 2020
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anakinra treatment, covid-19 infection, optimized standard of care (osoc)